NCT02095990View on ClinicalTrials.gov

Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma

PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Facial Melasma
Interventions
DRUG

Hydroquinone

DRUG

Placebo

Trial Locations (1)

08036

Hospital Clinic de Barcelona, Barcelona

All Listed Sponsors
lead

Mesoestetic Pharma Group S.L.

INDUSTRY

NCT02095990 - Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma | Biotech Hunter | Biotech Hunter